227
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx

, ORCID Icon, & ORCID Icon
Pages 7529-7536 | Received 04 Oct 2022, Accepted 09 Dec 2022, Published online: 21 Dec 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.